Slash breast cancer risk with a common sleep aid | |||
Dear Reader, I almost never talk about animal studies. (If you really want my attention, you've got to show me research on humans.) But I'm going to make an exception today. Because this is too important not to share: A team of researchers recently found that melatonin can slow breast cancer tumor growth in mice. This animal study showed that melatonin supplementation was able to block the growth of tumors and new blood vessels that support tumor growth. (A process known as angiogenesis.) After three weeks, mice receiving melatonin had significantly smaller tumor volume than controls, as well as less vascular growth in those tumors. What's more, none of the mice on melatonin suffered from weight loss or lethargy during that time period. In fact these mice seemed to have extra energy as a result. This is really exciting stuff. Because basically, it says that melatonin supplements do exactly what chemotherapy drugs do. Without ravaging your body in the process. Now, like most people, you might have thought melatonin was only good for one thing--as a sleep aid. But if you've been a reader of mine for a while, then you'll remember that it actually does a whole lot more than that. That's partly because melatonin is a powerful antioxidant. (Among its other noteworthy properties.) Something I explained back in the September 2013 issue of my monthly newsletter, Logical Health Alternatives. (If you're not a subscriber yet, consider signing up now.) I shared some of the more impressive research behind melatonin in that issue. And not just animal studies, either. Actual human studies also show that low levels of melatonin raise breast cancer risk. And higher levels seem to slow breast tumor growth. Research also shows that supplementing with melatonin can even minimize the side effects of chemotherapy--as well as shrink tumors that won't respond to tamoxifen treatment alone.
|
Tuesday, March 25, 2014
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment